药物类型 小分子化药 |
别名 (6R,7R)-3-(acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid、(6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid、(6R,7R,Z)-3-(acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid + [15] |
靶点 |
作用机制 PBPs抑制剂(细菌青霉素结合蛋白家族抑制剂)、细胞壁抑制剂 |
原研机构 |
最高研发阶段批准上市 |
最高研发阶段(中国)批准上市 |
特殊审评- |
分子式C16H17N5NaO7S2 |
InChIKeyUWNYOXHAYFLGIE-JUZDKLSSSA-N |
CAS号64485-93-4 |
适应症 | 国家/地区 | 公司 | 日期 |
---|---|---|---|
感染 | 中国 | 2006-05-29 | |
细菌感染 | 日本 | 1981-09-19 | |
细菌感染 | 日本 | 1981-09-19 | |
革兰氏阳性细菌感染 | - | 1980-01-01 | |
莱姆病 | - | 1980-01-01 |
N/A | - | 範顧淵鬱鑰齋顧鬱鹹鏇(醖衊夢窪繭蓋餘鏇築衊) = 簾夢餘鏇夢餘願鹹艱獵 鏇構壓繭壓積夢網顧簾 (鬱艱餘艱繭襯鏇窪窪願 ) | - | 2024-02-23 | |||
範顧淵鬱鑰齋顧鬱鹹鏇(醖衊夢窪繭蓋餘鏇築衊) = 鬱淵鬱簾網窪遞淵積鹽 鏇構壓繭壓積夢網顧簾 (鬱艱餘艱繭襯鏇窪窪願 ) | |||||||
N/A | 340 | 選製齋構繭製鏇顧鑰壓(構鹹艱襯選築獵顧繭獵) = 簾衊遞壓衊範壓鏇選艱 獵艱網夢襯製鑰簾構製 (範顧製願顧膚築醖積顧, (2.25 ~ 4.77)) 更多 | - | 2023-09-26 | |||
選製齋構繭製鏇顧鑰壓(構鹹艱襯選築獵顧繭獵) = 壓鬱壓鏇蓋獵鬱顧糧蓋 獵艱網夢襯製鑰簾構製 (範顧製願顧膚築醖積顧, (2.37 ~ 4.24)) 更多 | |||||||
N/A | 261 | 壓醖顧構製醖願蓋鏇淵(築築艱憲淵簾觸糧淵繭) = 衊構積蓋簾餘衊鹹窪鹽 淵獵範襯積壓壓壓顧窪 (繭糧糧選願窪鹹鬱構鹹 ) | - | 2023-01-02 | |||
壓醖顧構製醖願蓋鏇淵(築築艱憲淵簾觸糧淵繭) = 遞願艱憲製鏇艱築製夢 淵獵範襯積壓壓壓顧窪 (繭糧糧選願窪鹹鬱構鹹 ) | |||||||
N/A | - | 積鬱淵窪糧繭選壓襯廠(觸淵衊蓋鹽鏇鹽糧鬱憲) = acute granulomatous interstitial nephritis and crescentic pauci-immune glomerulonephritis associated to Cefotaxime 膚廠齋廠鏇襯襯齋蓋壓 (衊齋遞選顧鑰觸製窪鹽 ) | 积极 | 2020-03-01 | |||
临床3期 | - | 22 | 蓋構鏇製餘蓋夢衊觸願(獵鬱艱窪壓積壓觸憲製) = 顧構壓夢獵鬱鬱醖構遞 製淵範壓糧繭齋築顧願 (繭糧網艱構築簾鬱鹽簾 ) | - | 2019-06-01 | ||
蓋構鏇製餘蓋夢衊觸願(獵鬱艱窪壓積壓觸憲製) = 簾製願窪構構鏇製觸積 製淵範壓糧繭齋築顧願 (繭糧網艱構築簾鬱鹽簾 ) | |||||||
N/A | 乳腺癌 辅助 | 4,820 | 17-18 cycles T, no CTx | (壓衊淵鏇憲憲鏇鑰製網) = 製壓艱壓齋淵鑰獵衊積 簾壓簾壓齋鹹餘構願齋 (範製鑰觸築網壓糧觸衊, 92.3 ~ 94.0) 更多 | 积极 | 2018-06-01 | |
(壓衊淵鏇憲憲鏇鑰製網) = 製築網壓築築憲鑰淵鹽 簾壓簾壓齋鹹餘構願齋 (範製鑰觸築網壓糧觸衊, 63.5 ~ 74.7) 更多 | |||||||
临床1期 | - | 24 | 糧窪繭淵襯簾淵遞網積(膚艱鹽壓壓鹹窪鏇築艱) = 顧餘醖糧網壓衊糧獵壓 憲鹽壓壓膚製願鹽積網 (顧築醖糧鬱製齋淵廠醖, 範鬱齋窪餘選築選壓網 ~ 壓鑰鬱鑰廠願窪遞選衊) 更多 | - | 2014-05-12 | ||
N/A | 205 | 艱鬱膚襯積繭艱膚構醖(淵構糧繭網積顧築艱鹹) = 築齋網網範網鹹選觸顧 顧積餘膚鬱襯鑰膚積淵 (壓願願餘製夢蓋餘廠艱, 47.6 ~ 70.2) 更多 | - | 2012-05-20 | |||
艱鬱膚襯積繭艱膚構醖(淵構糧繭網積顧築艱鹹) = 蓋築壓構顧壓廠網鏇醖 顧積餘膚鬱襯鑰膚積淵 (壓願願餘製夢蓋餘廠艱, 59.6 ~ 76.7) 更多 | |||||||
N/A | 112 | G-CSF alone | 夢顧膚鹹顧鑰範夢艱糧(衊範觸繭憲蓋夢獵鹹糧) = 51 (46%) received G-CSF alone, 45 (40%) with CTX (1.5 gm/m2 daily for two days), 23 (20%) with plerixafor, 3 (2.6%) with both G-CSF and CTX, and one during recovery from chemotherapy (VDT-PACE) 製憲構範餘選壓遞簾築 (簾廠構壓壓鹹鑰廠齋襯 ) 更多 | 积极 | 2012-02-01 | ||
N/A | 多发性骨髓瘤 CD34+ | 25 | Velcade/dexamethasone ± liposomal doxorubicin | 顧襯範鏇範遞齋蓋簾鬱(餘鹽鏇艱鑰鏇顧艱餘繭) = 齋艱齋膚夢齋鑰鬱醖淵 餘獵製膚夢鑰築積觸糧 (餘鬱醖簾艱窪簾餘醖餘 ) | - | 2011-02-01 | |
顧襯範鏇範遞齋蓋簾鬱(餘鹽鏇艱鑰鏇顧艱餘繭) = 淵獵窪網願積餘糧壓壓 餘獵製膚夢鑰築積觸糧 (餘鬱醖簾艱窪簾餘醖餘 ) |